Literature DB >> 22360322

New regulation mechanisms of osteoclast differentiation.

Tomoki Nakashima1, Hiroshi Takayanagi.   

Abstract

Osteoclasts play a crucial role in both physiological and pathological bone resorption. It is, thus, of compelling importance to understand the molecular mechanisms of osteoclast regulation. Because receptor activator of nuclear factor-κB ligand (RANKL) is the key cytokine that induces osteoclast differentiation, we have focused on the investigation of RANKL signaling and RANKL-expressing cells. Here, we summarize the recent advances in the understanding of osteoclastogenic signaling and the cells that express RANKL in the context of osteoimmunology. The scope of osteoimmunology has been extended to now encompass a wide range of molecular and cellular interactions, and its framework provides a scientific basis for future therapeutic approaches to diseases related to the bone and/or immune systems.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22360322     DOI: 10.1111/j.1749-6632.2011.06373.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  53 in total

1.  Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis.

Authors:  Ran Gu; Leilani L Santos; Devi Ngo; HuaPeng Fan; Preetinder P Singh; Gunter Fingerle-Rowson; Richard Bucala; Jiake Xu; Julian M W Quinn; Eric F Morand
Journal:  Cytokine       Date:  2015-01-31       Impact factor: 3.861

2.  Adipocytes enhance expression of osteoclast adhesion-related molecules through the CXCL12/CXCR4 signalling pathway.

Authors:  Tingting Luo; Hongrui Liu; Wei Feng; Di Liu; Juan Du; Jing Sun; Wei Wang; Xiuchun Han; Jie Guo; Norio Amizuka; Xianqi Li; Minqi Li
Journal:  Cell Prolif       Date:  2016-11-21       Impact factor: 6.831

Review 3.  Podosome organization drives osteoclast-mediated bone resorption.

Authors:  Dan Georgess; Irma Machuca-Gayet; Anne Blangy; Pierre Jurdic
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

4.  Association of toll-like receptor 4 signaling pathway with steroid-induced femoral head osteonecrosis in rats.

Authors:  Lei Tian; Dong-Sheng Zhou; Kun-Zheng Wang; Wei Zhang; Zhi-Bin Shi; Li-Hong Fan; Shui Sun
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

5.  The many ways of osteoclast activation.

Authors:  Joseph Lorenzo
Journal:  J Clin Invest       Date:  2017-05-22       Impact factor: 14.808

6.  Histochemical evidence of IGF2 mRNA-binding protein 2-mediated regulation of osteoclast function and adhesive ability.

Authors:  Hongrui Liu; Dongfang Li; Shanshan Liu; Zhaopeng Liu; Minqi Li
Journal:  Histochem Cell Biol       Date:  2018-01-10       Impact factor: 4.304

7.  Hypoxia-Sensitive COMMD1 Integrates Signaling and Cellular Metabolism in Human Macrophages and Suppresses Osteoclastogenesis.

Authors:  Koichi Murata; Celestia Fang; Chikashi Terao; Eugenia G Giannopoulou; Ye Ji Lee; Min Joon Lee; Se-Hwan Mun; Seyeon Bae; Yu Qiao; Ruoxi Yuan; Moritoshi Furu; Hiromu Ito; Koichiro Ohmura; Shuichi Matsuda; Tsuneyo Mimori; Fumihiko Matsuda; Kyung-Hyun Park-Min; Lionel B Ivashkiv
Journal:  Immunity       Date:  2017-07-18       Impact factor: 31.745

8.  C/EBPα regulates osteoclast lineage commitment.

Authors:  Wei Chen; Guochun Zhu; Liang Hao; Mengrui Wu; Hongliang Ci; Yi-Ping Li
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-11       Impact factor: 11.205

9.  RBP-J-Regulated miR-182 Promotes TNF-α-Induced Osteoclastogenesis.

Authors:  Christine H Miller; Sinead M Smith; Mahmoud Elguindy; Tuo Zhang; Jenny Z Xiang; Xiaoyu Hu; Lionel B Ivashkiv; Baohong Zhao
Journal:  J Immunol       Date:  2016-05-09       Impact factor: 5.422

Review 10.  Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis.

Authors:  Alan Sućur; Vedran Katavić; Tomislav Kelava; Zrinka Jajić; Natasa Kovačić; Danka Grčević
Journal:  Int Orthop       Date:  2014-06-10       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.